THE IMPACT OF THE FDA'S RISK EVALUATION AND MITIGATION STRATEGIES (REMS) INITIATIVE ON PRESCRIPTION PATTERN FOR DRUGS APPROVED UNDER THE REMS PROGRAM AND RELEVANT NON-REMS COMPETITORS
被引:0
作者:
Horowicz-Mehler, N.
论文数: 0引用数: 0
h-index: 0
机构:
Quintiles Global Consulting, Hawthorne, NY USAQuintiles Global Consulting, Hawthorne, NY USA
Horowicz-Mehler, N.
[1
]
Sepulveda, B.
论文数: 0引用数: 0
h-index: 0
机构:
Quintiles Global Consulting, Hawthorne, NY USAQuintiles Global Consulting, Hawthorne, NY USA
Sepulveda, B.
[1
]
White, C.
论文数: 0引用数: 0
h-index: 0
机构:
Quintiles Global Consulting, Hawthorne, NY USAQuintiles Global Consulting, Hawthorne, NY USA
White, C.
[1
]
Doyle, J.
论文数: 0引用数: 0
h-index: 0
机构:
Quintiles Global Consulting, Hawthorne, NY USAQuintiles Global Consulting, Hawthorne, NY USA
Doyle, J.
[1
]
机构:
[1] Quintiles Global Consulting, Hawthorne, NY USA